Tag: Race

Companies Race to Develop Drugs That Stay Ahead of Coronavirus Mutations

Drugmakers are racing to develop a new generation of Covid-19 medicines to make them easier to give to patients and to stay ahead of virus mutations that could make some current drugs less effective. The drugs, known as monoclonal antibodies, are lab-engineered versions of antibodies that simulate the body’s natural immune response to viruses. They are considered among the most… Read more →